v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 12,689,161 $ 6,062,173
Prepaid research and development 9,931 9,931
Prepaid expenses and other current assets 265,897 389,501
Total Current Assets 12,964,989 6,461,605
Other Assets:    
Fixed Assets, net 56,218 58,149
Intangible assets, net 4,900 5,041
Acquired in-process research and development 455,000 455,000
Right-to-use Asset 233,570 246,209
Goodwill 248,971 248,971
Total Assets 13,963,648 7,474,975
Current Liabilities:    
Accounts payable 415,086 286,192
Accrued expenses 1,694,831 2,376,930
Lease liability, current 51,351 49,585
Other current liabilities 9,859 9,683
Total Current Liabilities 2,171,127 2,722,390
Contingent liabilities 868,000 1,014,000
Lease liability, non-current 193,797 207,375
Deferred tax liability 23,399 23,399
Total Liabilities 3,256,323 3,967,164
Commitments and contingencies
Shareholders’ Equity    
Preferred Stock, 5,000,000 shares authorized with a par value of $0.001 per share, 0 shares outstanding at March 31, 2022 and December 31, 2021
Common Stock, 50,000,000 shares authorized with a par value of $0.001 per share, 23,482,850 and 20,946,712 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 23,719 20,947
Additional paid in capital 64,534,560 54,429,979
Accumulated deficit (53,850,954) (50,943,115)
Total Shareholders’ Equity 10,707,325 3,507,811
Total Liabilities and Shareholders’ Equity $ 13,963,648 $ 7,474,975

Source